Recognizing the significant impact that diversity has on the nation's ability to improve autoimmune outcomes and advance health equity, SWHR developed the policy brief, “The Need for Diversity in Autoimmune Disease Research Trials.”
While the United States has made progress to close the gaps that have resulted from the historical exclusion of women […]
During this SWHR Instagram Live event, hear from experts about why clinical trial representation is critical for improving outcomes, where they see the greatest issues in clinical trial representation, and if federal proposals to rectify underrepresentation of certain populations could improve involvement.
Dr. Marie Bernard, NIH Chief Officer for Scientific Workforce Diversity spoke to SWHR Policy Advisory Council members about diversity’s impact on science, the NIH-Wide Strategic Plan for DEIA, COSWD’s recent efforts, and the NIH UNITE Initiative.
The Friends of the Office of Research on Women’s Health invite you to a congressional reception in celebration of Women’s […]
In an effort to highlight and address disparities in women’s health across the lifespan, SWHR launched the Women’s Health Dashboard, as a centralized platform explore the latest data on health conditions and diseases that have significant impacts on women’s health.
The Society for Women’s Health Research (SWHR) President and CEO Kathryn Schubert joined a group of health equity experts in […]
In 2019, SWHR conceived a set of principles to help ensure value frameworks and assessments reflected factors relevant to women […]
Published in Health Equity, this discussion transcript focuses on how the COVID-19 pandemic brought to light the serious and pervasive […]
The NASEM report on improving representation in clinical trials outlines the high cost of care and poor patient outcomes that are a consequence of not increasing diversity in research.